Dual CCR2/CCR5 antagonism as macrophage targeted therapy in experimental hepatocellular carcinoma

被引：0
|
作者：
Degroote, Helena [1 ]
Vandierendonck, Astrid [2 ]
Xavier, Verhelst [1 ]
Anja, Geerts [1 ]
Hans, Van Vlierberghe [1 ]
Devisscher, Lindsey [2 ]
机构：
[1] Ghent Univ Hosp, Gastroenterol & Hepatol, Ghent, Belgium
[2] Univ Ghent, Basic & Appl Med Sci, Gut Liver Immunopharmacol Unit, Ghent, Belgium
来源：
JOURNAL OF HEPATOLOGY | 2019年 / 70卷 / 01期
关键词：
D O I：
10.1016/S0618-8278(19)30701-7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU-454
引用
收藏
页码：E359 / E359
页数：1
相关论文
共 50 条
  • [1] Dual Targeting Of Ccr2 And Ccr5 For Treating Pulmonary Hypertension
    Parpaleix, A.
    Amsellem, V.
    Abid, S.
    Houssaini, A.
    Breau, M.
    Marcos, E.
    Sawaki, D.
    Bizard, E.
    Hubeau, C.
    Evans, S. E.
    Delcroix, M.
    Quarck, R.
    Adnot, S.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [2] Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
    Laura Fantuzzi
    Maria Tagliamonte
    Maria Cristina Gauzzi
    Lucia Lopalco
    Cellular and Molecular Life Sciences, 2019, 76 : 4869 - 4886
  • [3] A dual CCR2/CCR5 chemokine antagonist, BMS-813160?
    Norman, Peter
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2011, 21 (12) : 1919 - 1924
  • [4] Discovery of a Potent and Orally Bioavailable CCR2 and CCR5 Dual Antagonist
    Pasternak, Alexander
    Goble, Stephen D.
    Struthers, Mary
    Vicario, Pasquale P.
    Ayala, Julia M.
    Di Salvo, Jerry
    Kilburn, Ruth
    Wisniewski, Thomas
    DeMartino, Julie A.
    Mills, Sander G.
    Yang, Lihu
    ACS MEDICINAL CHEMISTRY LETTERS, 2010, 1 (01): : 14 - 18
  • [5] Dual CCR5/CCR2 targeting: opportunities for the cure of complex disorders
    Fantuzzi, Laura
    Tagliamonte, Maria
    Gauzzi, Maria Cristina
    Lopalco, Lucia
    CELLULAR AND MOLECULAR LIFE SCIENCES, 2019, 76 (24) : 4869 - 4886
  • [6] Dual targeting of CCR2 and CCR5: therapeutic potential for immunologic and cardiovascular diseases
    Zhao, Qihong
    JOURNAL OF LEUKOCYTE BIOLOGY, 2010, 88 (01) : 41 - 55
  • [7] Eotaxin is a natural antagonist for CCR2 and an agonist for CCR5
    Ogilvie, P
    Bardi, G
    Clark-Lewis, I
    Baggiolini, M
    Uguccioni, M
    BLOOD, 2001, 97 (07) : 1920 - 1924
  • [8] CCR5 and CCR2 gene polymorphisms in hypertensive patients
    Mettimano, M
    Specchia, ML
    Ianni, A
    Arzani, D
    Ricciardi, G
    Savi, L
    Romano-Spica, V
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2003, 60 (01) : 19 - 21
  • [9] Concerted evolution of vertebrate CCR2 and CCR5 genes and the origin of a recombinant equine CCR5/2 gene
    Perelygin, Andrey A.
    Zharkikh, Andrey A.
    Astakhova, Natalia M.
    Lear, Teri L.
    Brinton, Margo A.
    JOURNAL OF HEREDITY, 2008, 99 (05) : 500 - 511
  • [10] The dual CCR2/CCR5 inhibitor Cenicriviroc ameliorates murine primary biliary cholangitis
    Reuveni, D.
    Leung, P.
    Vig, P.
    Shibolet, O.
    Gershwin, E. M.
    Zigmond, E.
    JOURNAL OF HEPATOLOGY, 2017, 66 (01) : S75 - S76
12345